Treatment of ALT-positive sarcomas with tBHP resulted in markers of hyper-ALT, including increased APBs, increased telomere clustering/intensity and replication stress (Fig. 7H–L and Supplementary Fig. S11A and B). The gene discussed is GPT; the disease is sarcoma.